Cardiac strangulation following epicardial pacemaker implantation: a rare pediatric complication

Erick M Carreras1, Walter J Duncan2, Ognjenka Djurdjev3

  • 1Division of Pediatric Cardiovascular and Thoracic Surgery, Department of Surgery, BC Children's Hospital, Provincial Health Services Authority, Vancouver, British Columbia, Canada; Division of Cardiovascular Surgery, Department of Surgery, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Insights

Cardiac strangulation (CS) incidence was 2.3% with 1.2% mortality. Consistent imaging is crucial for diagnosing CS, especially in infants under six months receiving epicardial pacemakers.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Medical Device Technology

Background:

  • Cardiac strangulation (CS) is a rare but serious complication of epicardial pacemaker implantation.
  • Two cases of CS at the institution prompted an investigation into its incidence and diagnosis.

Purpose of the Study:

  • To determine the incidence of cardiac strangulation (CS).
  • To develop a clinical pathway for CS diagnosis and prognosis.

Main Methods:

  • Retrospective review of 86 patients who underwent epicardial pacemaker implantation (1992-2012).
  • Prospective imaging of 84 patients to assess lead placement and identify CS indicators.
  • Analysis of health records and radiographic imaging.

Main Results:

  • An overall incidence of 2.3% and a mortality rate of 1.2% related to CS were observed.
  • Posterior looping of the ventricular lead on radiographs was associated with CS.
  • Five variables were significantly linked to CS outcomes (P = .0153).

Conclusions:

  • Lack of consistent imaging, not follow-up, contributed to CS cases.
  • Consistent radiographic imaging is vital for early CS diagnosis.
  • Particular attention to lead placement and follow-up is recommended for patients ≤6 months at implantation.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
442
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
811
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
600
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
556
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
724